Patients' adherence to secondary prevention pharmacotherapy after acute coronary syndromes

被引：0
|
作者：
Kassab, Y. W. [1 ]
AbdulRazzaq, H. A. [1 ]
Altaie, A. H. [2 ]
Hassan, Y. [3 ]
Abd Aziz, N. [3 ]
Najjar, M. F. [4 ]
Ismail, O. [5 ]
机构：
[1] Univ Sci Malaysia, Sch Pharmaceut Sci, George Town, Malaysia
[2] Ankara Univ, Tomer Inst, TR-06100 Ankara, Turkey
[3] Univ Teknol MARA, Fac Pharm, Kuala Lumpur, Malaysia
[4] King Abdullah Int Med Res Ctr, Dept Clin Pharm, Riyadh, Saudi Arabia
[5] Hosp Pulau Pinang, Dept Cardiol, George Town, Malaysia
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2013年 / 35卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：911 / 911
页数：1
相关论文
共 50 条
  • [31] Impact of a supervised exercise rehabilitation program on secondary prevention goals after acute coronary syndromes
    Batista, I. B. Ignacio
    Fernandez, H. F. Horacio
    Berro, M. B. Mariano
    Lipszyc, F. I. Federico
    Bonorino, J. B. Jose
    Pastori, L. P. Luciano
    Baratta, S. B. Sergio
    O'Flaherty, M. O. Martin
    Lacometti, G. L. Gilbert
    Hita, A. H. Alejandro
    CIRCULATION, 2008, 118 (12) : E267 - E267
  • [32] ACUTE CORONARY SYNDROMES Acute coronary syndromes: key role of rehabilitation and primary care in long term secondary prevention
    Dalal, Hasnain M.
    Wingham, Jenny
    Taylor, Rod S.
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
  • [33] The Role of the Novel Oral Anticoagulants in the Secondary Prevention of Acute Coronary Syndromes
    Sharma, Rajat
    Bainey, Kevin R.
    CARDIOLOGY IN REVIEW, 2015, 23 (02) : 99 - 102
  • [34] Economic evaluation of ticagrelor for secondary prevention following acute coronary syndromes
    Gouveia, Miguel
    Borges, Margarida
    Trindade, Rosario
    Rikner, Klas
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2015, 34 (01) : 17 - 25
  • [35] Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study
    Lindhardsen, Jesper
    Ahlehoff, Ole
    Gislason, Gunnar Hilmar
    Madsen, Ole Rintek
    Olesen, Jonas Bjerring
    Torp-Pedersen, Christian
    Hansen, Peter Riis
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (09) : 1496 - 1501
  • [36] Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention after Acute Coronary Syndromes: a Review
    Peter Khalil
    Ghazal Kabbach
    Current Cardiology Reports, 2019, 21
  • [37] A pragmatic approach for thrombotic prevention after acute coronary syndromes
    Cesaro, Arturo
    Acerbo, Vincenzo
    Gragnano, Felice
    Calabro, Paolo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2025, 422
  • [38] Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention after Acute Coronary Syndromes: a Review
    Khalil, Peter
    Kabbach, Ghazal
    CURRENT CARDIOLOGY REPORTS, 2019, 21 (01)
  • [39] Adherence to secondary prevention medication early after acute stroke
    Al AlShaikh, S. A.
    Dawson, J.
    Walters, M.
    Fulton, R.
    Bath, P.
    Shuaib, A.
    CEREBROVASCULAR DISEASES, 2014, 37 : 432 - 432
  • [40] Connect: secondary prevention after an acute coronary syndrome: are elderly patients different?
    Dujardin, J. J.
    Asseman, P.
    Dallongeville, J.
    Philippe, F.
    Sabouret, P.
    Gattolliat, O.
    Borentain, M.
    Montalescot, G.
    EUROPEAN HEART JOURNAL, 2008, 29 : 17 - 17
12345